Untargeted metabolome analysis revealed that that SLC44A2-regulated metabolites were primarily enriched in energy metabolism pathways, including the “TCA cycle,” “oxidative phosphorylation,” and “central carbon metabolism in cancer” (Fig. 3A). The gene discussed is SLC44A2; the disease is cancer.